ACM
LKFT

Aquatic Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Aquatic Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Sell
11,859
-1,853
-14% -$61.4K 0.01% 854
2025
Q4 		$448K Sell
13,712
-3,804
-22% -$123K 0.01% 767
2025
Q3 		$607K Buy
17,516
+6,807
+64% +$218K 0.01% 820
2025
Q2 		$300K Sell
10,709
-13,316
-55% -$357K 0.01% 945
2025
Q1 		$604K Sell
24,025
-2,393
-9% -$60.5K 0.02% 720
2024
Q4 		$726K Buy
+26,418
New +$736K 0.02% 628
2024
Q3 		– Sell
-5,800
Closed -$144K – 1293
2024
Q2 		$144K Sell
5,800
-1,100
-16% -$31.2K 0.01% 829
2024
Q1 		$222K Buy
6,900
+1,200
+21% +$44.6K 0.01% 737
2023
Q4 		$232K Buy
5,700
+3,700
+185% +$136K 0.01% 815
2023
Q3 		$69K Buy
2,000
+1,800
+900% +$70.1K ﹤0.01% 903
2023
Q2 		$8K Buy
+200
New +$8.16K ﹤0.01% 1214
2022
Q4 		– Sell
-8,200
Closed -$350K – 1539
2022
Q3 		$350K Buy
8,200
+6,000
+273% +$307K 0.03% 490
2022
Q2 		$123K Buy
2,200
+2,000
+1,000% +$119K 0.04% 437
2022
Q1 		$12K Sell
200
-1,800
-90% -$110K 0.02% 617
2021
Q4 		$110K Buy
+2,000
New +$104K 0.21% 113

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aquatic Capital Management's LKFT Position: Q1 2026 in Review

Aquatic Capital Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 14% in Q1 2026, selling an estimated $61.4K and leaving 11,859 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #854.

Aquatic Capital Management first reported a position in LKFT in Q4 2021 and has held it in 15 quarters since. The position peaked at $726K in Q4 2024. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Aquatic Capital Management held 11,859 shares of Lakefront Biotherapeutics American Depositary Shares worth $356K as of Q1 2026.
  • Aquatic Capital Management sold 1,853 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $61.4K.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #854 holding.
  • Aquatic Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2021 and has held it in 15 quarters since.
  • Aquatic Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $726K in Q4 2024.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.